Explorative Analysis of Treatment Outcomes of Levofloxacin- and Moxifloxacin-Based Regimens and Outcome Predictors in Ethiopian MDR-TB Patients: A Prospective Observational Cohort Study
Temesgen Sidamo,1 Workineh Shibeshi,1 Getnet Yimer,2 Eleni Aklillu,3 Ephrem Engidawork1 1Department of Pharmacology & Clinical Pharmacy, School of Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia; 2Global One Health Initiative, Office of International Affairs,...
Main Authors: | Sidamo T, Shibeshi W, Yimer G, Aklillu E, Engidawork E |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-12-01
|
Series: | Infection and Drug Resistance |
Subjects: | |
Online Access: | https://www.dovepress.com/explorative-analysis-of-treatment-outcomes-of-levofloxacin--and-moxifl-peer-reviewed-fulltext-article-IDR |
Similar Items
-
Population Pharmacokinetics of Levofloxacin and Moxifloxacin, and the Probability of Target Attainment in Ethiopian Patients with Multidrug-Resistant Tuberculosis
by: Sidamo T, et al.
Published: (2022-11-01) -
Two Eco-Friendly Chromatographic Methods Evaluated by GAPI for Simultaneous Determination of the Fluoroquinolones Moxifloxacin, Levofloxacin, and Gemifloxacin in Their Pharmaceutical Products
by: Eman A. Abdel Hameed, et al.
Published: (2022-10-01) -
Effectiveness and safety of Levofloxacin containing regimen in the treatment of Isoniazid mono-resistant pulmonary Tuberculosis: a systematic review
by: Leeberk Raja Inbaraj, et al.
Published: (2023-06-01) -
Inhibitory Activity of Levofloxacin against MDR Staphylococcus aureus and Pseudomonas aeruginosa Clinical Isolates
by: Lisa Nathalie, et al.
Published: (2019-07-01) -
Data in Brief of: Clinical benefits of moxifloxacin as initial treatment of community-acquired pneumonia: Data from meta-analyses
by: Xiwen Du, et al.
Published: (2021-10-01)